Moreover, this study demonstrated that the effect and mechanism of PTPN18 on promoting glioblastoma are mediated by reducing immune infiltration and enhancing immune suppression, indicating the potential value of targeting PTPN18 as an immunotherapy strategy for glioblastoma. The gene discussed is PTPN18; the disease is glioblastoma.